Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN273201400017C
IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTE OF HEALTH NIEHS |
| NAICS | 541712 |
| PSC | AZ11 — OTHER RESEARCH AND DEVELOPMENT - BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $30.2M |
| Current contract value | $32.3M |
| Potential contract value / ceiling | $48.8M |
| Start date | Aug 13, 2014 |
| Current end date | Feb 12, 2026 |
| Potential end date | Feb 12, 2026 |
| Latest award activity | Feb 12, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 30 of 30 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 12, 2026 | P00029 | $25.0K | STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL & THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 12, 2025 | P00028 | $600.0K | STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL & THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 8, 2025 | P00027 | $-298.5K | STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL & THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Dec 5, 2024 | P00026 | $0 | REMOVE SUBCONTRACTOR EI GROUP (CEI). ADD CONSULTANT J. LINDSAY COOK, INDUSTRIAL HYGIENIST |
| Sep 12, 2024 | P00025 | $-65.1K | DE-OBLIGATE REMAINING FUNDING ON LINE 25 THAT WAS MISSED ON P00022. |
| Aug 23, 2024 | P00024 | $2.5M | ADD OPTION 1, YEAR 11 TO THE CONTRACT IN THE AMOUNT OF $4,158,012.15. EXERCISE OPTION 1, YEAR 11 WITH PARTIAL FUNDING IN THE AMOUNT OF $2,500,000.00. ADD OPTION 1 YEAR 12 (6-MONTH) TO BE EXERCISED AT A LATER DATE, AND REVISE ARTICLE B.2, B.3, B.4, F. |
| Jul 18, 2024 | P00023 | $370.0K | PROVIDE FUNDING INCREMENT OPTION 1, YEAR 10 IN THE AMOUNT OF $370,000.00 AND REVISE ARTICLE B.3 AND G.3 ACCORDINGLY. |
| Jul 5, 2024 | P00022 | $-153.3K | DE-OBLIGATE THE REMAINING FY19 FUNDING IN ACCORDANCE WITH 31 U.S.C. 1552(A), AND REVISE ARTICLE B.3 ACCORDINGLY. |
| Mar 12, 2024 | P00021 | $0 | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 11, 2023 | P00020 | $2.0M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| May 22, 2023 | P00019 | $-1.1M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Nov 16, 2022 | P00018 | $0 | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 8, 2022 | P00017 | $2.7M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 1, 2022 | P00016 | $-1.6M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Oct 15, 2021 | P00015 | $0 | EO14042 EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 12, 2021 | P00014 | $4.2M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Jun 29, 2021 | P00013 | $-918.1K | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Jun 3, 2021 | P00012 | $1.1M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 12, 2020 | P00011 | $3.0M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Jun 25, 2020 | P00010 | $500.0K | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Jun 3, 2020 | P00009 | $-1.5M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 7, 2019 | P00008 | $2.5M | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Jun 26, 2019 | P00007 | $-205.0K | EVALUATE THE POTENTIAL FOR AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 8, 2018 | 6 | $3.9M | IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 10, 2017 | 5 | $3.8M | IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Sep 28, 2016 | 4 | $0 | IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 12, 2016 | 3 | $3.7M | IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 13, 2015 | 2 | $3.6M | IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Jul 29, 2015 | 1 | $-2.0M | IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
| Aug 13, 2014 | 0 | $3.6M | IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.